Semaglutide Cardiac Remodeling

Source: Journal of the American College of Cardiology (2024).

Key finding: Favorable cardiac remodeling in HFpEF.

Part of GLP1Score's 20-study clinical evidence library — the peer-reviewed research powering our GLP-1 eligibility scoring engine.

Related Reading

Semaglutide in India — Complete Guide
Semaglutide Drug Monograph (dosing, contraindications)
Who Qualifies for Semaglutide in India
Semaglutide 2.4 mg for Weight Management in Overweight or Obese Adults with Type 2 Diabetes (STEP 2)
Metabolic Non-Communicable Disease Health Report of India: The ICMR-INDIAB National Cross-Sectional Study (INDIAB-17)
Metabolically Obese Normal Weight Phenotype in India (ICMR-INDIAB-23)

Take the Free Eligibility Assessment → · Compare All 18+ Brands